Presentation topic: Personal Health & Care 

Prof. Dr. Angela Brand, MD PhD MPH (USA) is Full Professor for Social Medicine & Public Health Genomics and Founding Director of the Institute for Public Health Genomics at the Faculty of Health, Medicine and Life Sciences (FHML) at Maastricht University as well as Professorial Fellow at UNU-MERIT (United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology), Maastricht, The Netherlands. She is also Dr. T.M.A. Pai Endowment Chair on Public Health Genomics and Head of the Department of Public Health Genomics at the Manipal School of Life Sciences as well as Adjunct Professor at the Prasanna School of Public Health at Manipal Manipal Academy of Higher Education (MAHE), India.

Prior to entering academia, she worked as a medical doctor in pediatrics and human genetics at various academic institutions and in governmental bodies in the USA and Germany. She is a Specialist in Public Health Medicine, holds a PhD in Pathology, a Master of Public Health (MPH) from Johns Hopkins University, USA, and received her habilitation from the University of Bremen, Germany, focusing on Health Technology Assessment.

She has been the pioneer of Public Health Genomics in Europe and successfully coordinated and established this field in more than 15 EU Member States within the last two decades. She has been founder and Editor-in-Chief (2009-2017) of Public Health Genomics, the leading international journal focusing on the responsible and timely translation of genome-based knowledge and technologies into public health, health policies, and health systems. She is Delegate of the Rockefeller Foundation, USA , Fellow of the 21st Century Trust of the Wellcome Trust, UK, and a Member of the New York Academy of Sciences.

For the Estonian Presidency of the Council of the European Union in 2017, she led Task Force 2 “Data Donors and Citizen-Controlled Data Governance” to prepare for the Digital Health Society in Europe and beyond. Among others, currently she is Member of the Board of Directors of the Digital Health Society (https://thedigitalhealthsociety.com), enabled by the European Connected Health Alliance (ECHAlliance, www.echalliance.com), Member of the Expert Group “Global Health Foresight” of the Science Division of the World Health Organization (WHO), and Member of the Advisory Board of the International Consortium Personalised Medicine (IC PerMed, www.icpermed.eu), jointly coordinated by the European Commission, over 26 European Member States and Canada.

She serves as Expert for the European Medicines Agency (EMA), the OECD, WHO, the EC, the German Robert Koch Institute (RKI), Genome Canada, Science Europe and AXA Research, amongst others. She also collaborates with industry partners such as IBM, Roche, Pfizer, AMGEN, Novartis, MSD and Bayer HealthCare. Her research focus is on Public Health Genomics (incl. One Health approach), Personalised Medicine & Personal Health & Care, Translational Research, AI and Big Data Analytics for Public Health, Public- private partnerships (PPP), Innovation Management, and Data Governance & Cooperative Health Ecosystems (e.g. Health Data Cooperatives).